Company: IXHL
Filing Date: 2025-10-27
Form Type: DEF 14A
Source: 0001213900-25-102654
Chunk: 29

Company: Incannex Healthcare Inc.
Filing Date: 2025-10-27
Form: DEF 14A
Chunk 29
---
 our affiliates and aligning their interests with those of our stockholders. Eligibility and administration.Employees, consultants, and directors of the Company and its affiliates, as well as prospective employees, consultants, and directors who have accepted offers of employment or consultancy from the Company or its affiliates are eligible to receive one or more types of Awards (as defined below) under the 2023 Plan. 20 The 2023 Plan is administered by a committee of at least two people as our board of directors may appoint or, if no such committee has been appointed by our board of directors, our board of directors (such committee, the “Committee”). The compensation committee of our board of directors currently serves as the Committee. Currently, Mr. Widdows and Mr. Clark are members of the Committee. The Committee has complete authority to determine which employees, consultants, and/or non-employee directors will be granted Awards under the 2023 Plan. The Committee members must qualify as “non-employee directors” under Rule 16b-3 of the Exchange Act. Subject to the terms of the 2023 Plan, the Committee has all discretion and authority to administer the 2023 Plan and to control its operation, in accordance with the 2023 Plan’s provisions, including, but not limited to, the power to (a) determine which employees, consultants, and non-employee directors will be granted Awards, (b) prescribe the terms and conditions of the Awards (which need not be the same), (c) interpret the 2023 Plan and the Awards, (d) adopt such procedures and/or subplans deemed necessary or appropriate for the purpose of satisfying applicable international laws or for qualifying for favorable tax treatment under applicable international laws, (e) to institute and determine the terms and conditions of an award exchange program; provided, however, that the Committee shall not implement an award exchange program without the approval of the majority of the Company’s stockholders entitled to vote at any annual or special meeting of Company’s stockholders, and (f) make whatever rules it considers appropriate for the administration and interpretation of the 2023 Plan. The Committee may delegate any of its authority and powers under the 2023 Plan to one or more officers of the Company. However, the Committee may not delegate its authority and powers with respect to any Awards that are granted to Company’s executive officers or directors who are subject to Section 16(b) of the Exchange Act. All interpretations, determinations and decisions made by the Committee, the board of